Qin He
Impact in
- Biomaterials top 0.1%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 0.5%
Papers in
- Biomaterials 70
- Nanoparticle-Based Drug Delivery 67
- Immunology 32
- Immunotherapy and Immune Responses 15
Qin He
170 papers receiving 6.9k citations
Peers
Comparison fields: 5 of 129
- Biomaterials 3.0k
- Pharmaceutical Science 487
- Biomedical Engineering 3.0k
- Molecular Biology 3.3k
- Immunology 994
Countries citing papers authored by Qin He
This map shows the geographic impact of Qin He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qin He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qin He more than expected).
Fields of papers citing papers by Qin He
This network shows the impact of papers produced by Qin He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qin He. The network helps show where Qin He may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qin He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 5 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 9 | |
| 9 | 2023 | 12 | |
| 10 | 2023 | 87 | |
| 11 | 2021 | 19 | |
| 12 | 2021 | 10 | |
| 13 | Anti-Tumor Activities of Bioactive Phytochemicals in Sophora flavescens for Breast Cancer | 2020 | 3 |
| 14 | 2019 | 82 | |
| 15 | 2018 | 61 | |
| 16 | 2018 | 33 | |
| 17 | 2017 | 22 | |
| 18 | A case-control study of seasonal influenza vaccine effectiveness for A(H1N1) pdm09 among children | 2014 | 1 |
| 19 | Clinical value in treatment with icotinib as first- line therapy in advanced non- small cell lung cancer | 2013 | 1 |
| 20 | 2009 | 31 |
About Qin He
Qin He is a scholar working on Biomaterials, Immunology, Biomedical Engineering, Physiology and Cancer Research, having authored 181 papers that have together received 7.0k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (67 papers), Nanoplatforms for cancer theranostics (59 papers), RNA Interference and Gene Delivery (50 papers), Advanced biosensing and bioanalysis techniques (26 papers), Autophagy in Disease and Therapy (17 papers), Immunotherapy and Immune Responses (15 papers), Extracellular vesicles in disease (13 papers) and Carbon and Quantum Dots Applications (12 papers). The work is most often cited by research in Biomaterials (3.0k citations), Pharmaceutical Science (487 citations), Biomedical Engineering (3.0k citations), Molecular Biology (3.3k citations) and Immunology (994 citations). Qin He has collaborated with scholars based in China, South Korea and United States. Frequent co-authors include Huile Gao, Zhirong Zhang, Man Li, Shaobo Ruan, Xingli Cun, Qianyu Zhang, Xian Tang, Kairong Shi, Qianwen Yu and Yue Qiu. Their work appears in journals such as Journal of Controlled Release, Acta Biomaterialia, ACS Applied Materials & Interfaces, International Journal of Pharmaceutics and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.